Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2005:759–769. doi: 10.1007/0-387-25518-4_41

The Role of Humoral Immunity in Mouse Hepatitis Virus Induced Demyelination

C Ramakrishna 3, S Tschen 4, C C Bergmann 4, S A Stohlman 3,5
Editors: Ehud Lavi1, Cris S Constantinescu2
PMCID: PMC7120426

Abstract

Pathogenesis induced by mouse hepatitis virus (MHV) infection of rodents is characterized by acute viral encephalomyelitis and demyelination which progresses to a persistent CNS infection associated with ongoing myelin loss, pathologically similar to multiple sclerosis (MS). Although humoral immunity appears redundant for the control of acute virus replication, it is vital in maintaining virus at levels detectable only by RNA analysis. T cell mediated control of acute infection cannot be sustained in antibody (Ab) deficient mice, resulting in virus reactivation. The protective role of Ab during persistence is strongly supported by detection of Ab in the cerebrospinal fluid of MHV infected rodents and maintenance of virus specific Ab secreting cells (ASC) in the CNS long after virus clearance. Ab mediated neutralization constitutes the major mechanism of protection, although fusion inhibition also plays a minor role. Delayed accumulation of ASC, concomitant with a decline in T cell function, assures control of residual virus while minimizing T cell mediated pathology. Although there is little evidence for a detrimental role of Ab in demyelination, an association between Ab mediated protection and remyelination is unclear.

Key words: CNS, demyelination, mouse hepatitis virus, B cells, Antibody

References

  • 1.Correale J., de Los Milagros Bassani Molinas M. Oligoclonal bands and antibody responses in Mulitple sclerosis. J Neurol. 2002;249:375–89. doi: 10.1007/s004150200026. [DOI] [PubMed] [Google Scholar]
  • 2.Connor O., Kevin C., Bar-Or A., Hafler D. A. The Neuroimmunology of Multiple Sclerosis: Possible roles of T and B lymphocytes in Immunopathogenesis. J Clin Immunol. 2001;21:81–92. doi: 10.1023/A:1011064007686. [DOI] [PubMed] [Google Scholar]
  • 3.Kabat E. A., Glusman M., Knaub V. Quantitative estimation of the albumin and gamma globulin in normal and pathologic cerebrospinal fluid by immunochemical methods. Am J Med. 1948;4:653–62. doi: 10.1016/S0002-9343(48)90389-1. [DOI] [PubMed] [Google Scholar]
  • 4.Bornstein M. B., Appel S. H. The application of tissue culture to the study of experimental allergic encephalomyelitis. I. Patterns of demyelination. J Neuropathol Exp Neurol. 1961;20:141–7. doi: 10.1097/00005072-196101000-00009. [DOI] [Google Scholar]
  • 5.Esiri M. M. Immunoglobulin-containing cells in multiple sclerosis plaques. Lancet. 1977;ii:478–80. doi: 10.1016/S0140-6736(77)91603-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Genain C. P., Cannella B., Hauser S. L., Raine C. S. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat. Med. 1999;5:170–5. doi: 10.1038/5532. [DOI] [PubMed] [Google Scholar]
  • 7.Cross A. H., Trotter J. L., Lyons J.-A. B cells and antibodies in CNS demyelinating disease. J Neurolmm. 2001;112:1–14. doi: 10.1016/s0165-5728(00)00409-4. [DOI] [PubMed] [Google Scholar]
  • 8.Colombo M., Dono M., Gazzola P., Roncella S., Valetto A., Chiorazi N., Mancardi G. L., Ferrarini M. Accumulation of clonally related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients. J Immunol. 2001;164:2782–89. doi: 10.4049/jimmunol.164.5.2782. [DOI] [PubMed] [Google Scholar]
  • 9.Gilden D. H., Devlin M. E., Burgoon M. P., Owens G. P. The search for virus in multiple sclerosis brain. Mult Scler. 1996;2:179–83. doi: 10.1177/135245859600200403. [DOI] [PubMed] [Google Scholar]
  • 10.Archelos J. J., Storch M. K., Hartung H.-P. The role of B cells and autoantibodies in Multiple sclerosis. Annals Neurol. 2000;47:694–706. doi: 10.1002/1531-8249(200006)47:6<694::AID-ANA2>3.0.CO;2-W. [DOI] [PubMed] [Google Scholar]
  • 11.Lumsden C. E. The immunopathogenesis of the multiple sclerosis plaque. Brain Res. 1971;28:365–90. doi: 10.1016/0006-8993(71)90052-7. [DOI] [PubMed] [Google Scholar]
  • 12.Stohlman S. A., Bergmann C. C., Perlman S. Mouse hepatitis virus. In: Ahmed R., Chen I., editors. Persistent Viral Infections. New York, NY: Wiley Publishers; 1999. [Google Scholar]
  • 13.Marten N. W., Stohlman S. A., Bergmann C. C. MHV infection of the CNS: Mechanisms of immune-mediated control. Viral Immunol. 2001;14:1–18. doi: 10.1089/08828240151061329. [DOI] [PubMed] [Google Scholar]
  • 14.Lin M. T., Hinton D. R., Marten N. W., Bergmann C. C., Stohlman S. A. Antibody prevents virus reactivation within the central nervous system. J Immunol. 1999;162:7358–68. [PubMed] [Google Scholar]
  • 15.Ramakrishna C., Stohlman S. A., Atkinson R., Shlomchik M. J., Bergmann C. C. Mechanisms of central nervous system viral persistence: the critical role of antibody and B cells. J Immunol. 2002;168:1204–11. doi: 10.4049/jimmunol.168.3.1204. [DOI] [PubMed] [Google Scholar]
  • 16.Matthews A. E., Weiss S. R., Shlomchik M. J., Hannum L. G., Gombold J. L., Paterson Y. Antibody is required for clearance of infectious murine hepatitis virus A59 from the central nervous system, but not the liver. J Immunol. 2001;167:5254–63. doi: 10.4049/jimmunol.167.9.5254. [DOI] [PubMed] [Google Scholar]
  • 17.Tschen S., Bergmann C. C., Ramakrishna C., Morales S., Atkinson R., Stohlman S. A. Recruitment kinetics and composition of antibody secreting cells within the central nervous system following viral encephalomyelitis. J. Immunol. 2002.;168:2922–29. doi: 10.4049/jimmunol.168.6.2922. [DOI] [PubMed] [Google Scholar]
  • 18.Fleming J. O., Shubin R. A., Sussman M. A., Casteel N., Stohlman S. A. Monoclonal antibodies to the matrix (El) glycoprotein of mouse hepatitis virus protect mice from encephalitis. Virology. 1989;168:162–7. doi: 10.1016/0042-6822(89)90415-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Buchmeier M. J., Lewicki H. A., Talbot P. J., Knobler R. L. Murine hepatitis virus-4 (strain JHM)-induced neurologic disease is modulated in vivo by monoclonal antibody. Virology. 1984;132:261–70. doi: 10.1016/0042-6822(84)90033-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Nakanaga K., Yamanouchi K., Fujiwara K. Protective effect of monoclonal antibodies on lethal mouse hepatitis virus infection in mice. J Virol. 1986;59:168–71. doi: 10.1128/jvi.59.1.168-171.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Perlman S., Schelper R., Bolger E., Ries D. Late onset, symptomatic, demyelinating encephalomyelitis in mice infected with MHV-JHM in the presence of maternal antibody. Microb Pathog. 1987;2:185–94. doi: 10.1016/0882-4010(87)90020-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Kolb A. J., Pewe L., Webster J., Perlman S., Whitelaw C. B., Siddel S. G. Virus-neutralizing monoclonal antibody expressed in milk of transgenic mice provides full protection against virus induced encephalitis. J. Virol. 2001;75:2803–9. doi: 10.1128/JVI.75.6.2803-2809.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Morales S., Parra B., Ramakrishna C., Blau D. M., Stohlman S. A. B cell mediated lysis of cells infected with the neurotropic JHM strain of mouse hepatitis virus. Virol. 2001;286:160–7. doi: 10.1006/viro.2001.0991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Slifka M. K., Ahmed R. Long lived plasma cells: a mechanism for maintaining persistent antibody production. Curr Opin Immunol. 1998;10:252–8. doi: 10.1016/S0952-7915(98)80162-3. [DOI] [PubMed] [Google Scholar]
  • 25.Knopf P.M., Harling-Berg C. J., Cserr H. F., Basu B., Sirulnick E. J., Nolan S. C., Park J. T., Keir G., Thompson E. T., Hickey W. F. Antigen-Dependent intrathceal antibody synthesis in the normal rat brain: Tissue Entry and local retention of Antigen specific B cells. J Immunol. 1998;161:692–701. [PubMed] [Google Scholar]
  • 26.Griffin D., Levine B., Tyor W., Ubol S., Despres P. The role of antibody in recovery from alphavirus encephalitis. Immunol Rev. 1997;159:155–61. doi: 10.1111/j.1600-065X.1997.tb01013.x. [DOI] [PubMed] [Google Scholar]
  • 27.Schwender S., Imrich H., Dorries R. The pathogenic role of virus-specific antibody secreting cells in the central nervous system of rats with different susceptibility to coronavirus-induced demyelinating encephalitis. Immunol. 1991;74:533–8. [PMC free article] [PubMed] [Google Scholar]
  • 28.Bergmann C. C., Ramakrishna C., Kornacki M., Stohlman S. A. Impaired T cell immunity in B cell-deficient mice following viral central nervous system infection. J. Immunol. 2001;167:1575–83. doi: 10.4049/jimmunol.167.3.1575. [DOI] [PubMed] [Google Scholar]
  • 29.Smith-Norowitz T. A., Sobel R. A., Mokhatarian F. B cells and antibodies in the pathogenesis of myelin injury in Semliki Forest Virus encephalomyelitis. Cell Immunol. 2000;200:27–35. doi: 10.1006/cimm.2000.1613. [DOI] [PubMed] [Google Scholar]
  • 30.Lin M. T., Stohlman S. A., Hinton D. R. Mouse hepatitis virus is cleared from the central nervous systems of mice lacking perforin-mediated cytolysis. J Virol. 1997;71:383–91. doi: 10.1128/jvi.71.1.383-391.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Ramakrishna C, Bergmann C. C., Atkinson R., Stohlman S. A. Control of central nervous system persistence by neutralizing antibody. J. Virol. Submitted. [DOI] [PMC free article] [PubMed]
  • 32.Furrer E., Bilzer T., Stitz L., Planz O. Neutralizing antibodies in persistent Borna disease virus infection: prophylactic effect of gp94-specific monoclonal antibodies in preventing encephalitis. J Virol. 2001;75:943–51. doi: 10.1128/JVI.75.2.943-951.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Lamarre A., Talbot P. J. Protection from lethal Coronavirus infection by immunoglobulin fragments. J Immunol. 1995;154:3975–84. [PubMed] [Google Scholar]
  • 34.Houtman J. J., Fleming J. O. Dissociation of demyelination and viral clearance in congenitally immunodeficient mice infected with murine coronavirus JHM. J Neurovirol. 1996;2:101–10. doi: 10.3109/13550289609146543. [DOI] [PubMed] [Google Scholar]
  • 35.Zimprich F., Winter J., Wege H., Lassmann H. Coronavirus induced primary demyelination: indications for the involvement of a humoral immune response. Neuropath Applied Neurobiol. 1991;17:469–84. doi: 10.1111/j.1365-2990.1991.tb00750.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Drescher K. M., Pease L. R., Rodriguez M. Antiviral immune responses modulate the nature of central nervous system (CNS) disease in a murine model of multiple sclerosis. Immunol Rev. 1997;159:177–93. doi: 10.1111/j.1600-065X.1997.tb01015.x. [DOI] [PubMed] [Google Scholar]

Articles from Experimental Models of Multiple Sclerosis are provided here courtesy of Nature Publishing Group

RESOURCES